# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-123592
Filing Date
2025-05-21
Accepted
2025-05-21 06:12:19
Documents
15
Period of Report
2025-07-10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d47501ddef14a.htm iXBRL | DEF 14A | 378886
3 | GRAPHIC | g47501dsp001.jpg | GRAPHIC | 226020
4 | GRAPHIC | g47501dsp002.jpg | GRAPHIC | 97047
5 | GRAPHIC | g47501g02a04.jpg | GRAPHIC | 58144
| Complete submission text file | 0001193125-25-123592.txt |  | 1624490

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | sttk-20241231.xsd | EX-101.SCH | 2504
17 | EXTRACTED XBRL INSTANCE DOCUMENT | d47501ddef14a_htm.xml | XML | 3109

Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39593 | Film No.: 25970829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)